ABEO CIK: 318306

Abeona Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0
FY25:
4.29
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.8
FY22:
−50.9
FY23:
−47.1
FY24:
−64.2
FY25:
−89.4
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−55.9
FY25:
–
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−63.7
FY25:
71.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.9
FY22:
−39.7
FY23:
−54.2
FY24:
−63.7
FY25:
71.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data